in this issue
ACC v. BPA
2:16 PM MDT | March 12, 2009 | By VINCENT VALK
ACC is continuing its fight against bans on bisephenol A (BPA). But what does the science say?
In a development that is likely to shock no one, the ACC is continuing to fight prospective BPA bans. The industry’s trade group noted in a letter to the Hartford Courant that human BPA exposure is typically 1,000 times lower than safe levels as defined by European authorities. Nevertheless, Suffolk County, New York recently passed a ban, and attorneys general in Delaware, New Jersey and Connecticut are seeking to curb BPA’s use.
If you listen to such authorities, you could be forgiven for assuming that BPA is almost radioactive. If you listen to the ACC, you might think that BPA is essentially harmless. The truth, it seems, may be somewhere in the middle.
A BPA study by the National Toxicology Program found “some concern for effects on the brain, behavior, and prostate gland in fetuses, infants, and children at current human exposures,” and “minimal concern for effects on the mammary gland and an earlier age for puberty for females in fetuses, infants, and children.” Other areas of potential concern were labeled as “negligible” (for further details, click the link).
What does that mean for those seeking to ban – or defend – BPA use? I’m not sure, but anyone concerned with the issue should consider the science before jumping to conclusions.